12:00 AM
Jun 04, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

OMS302: Phase III ongoing

Omeros began a planned pharmacokinetic substudy of OMS302 in 24 patients undergoing intraocular lens replacement surgery enrolled in an ongoing, double-blind, placebo-controlled Phase III trial. Blood samples will be collected prior to and during the first 24 hours...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >